Genes with relevance for early to late progression of colon carcinoma based on combined genomic and transcriptomic information from the same patients.
BACKGROUND
Genetic and epigenetic alterations in colorectal cancer are numerous. However, it is difficult to judge whether such changes are primary or secondary to the appearance and progression of tumors. Therefore, the aim of the present study was to identify altered DNA regions with significant covariation to transcription alterations along colon cancer progression.


METHODS
Tumor and normal colon tissue were obtained at primary operations from 24 patients selected by chance. DNA, RNA and microRNAs were extracted from the same biopsy material in all individuals and analyzed by oligo-nucleotide array-based comparative genomic hybridization (CGH), mRNA- and microRNA oligo-arrays. Statistical analyses were performed to assess statistical interactions (correlations, co-variations) between DNA copy number changes and significant alterations in gene and microRNA expression using appropriate parametric and non-parametric statistics.


RESULTS
Main DNA alterations were located on chromosome 7, 8, 13 and 20. Tumor DNA copy number gain increased with tumor progression, significantly related to increased gene expression. Copy number loss was not observed in Dukes A tumors. There was no significant relationship between expressed genes and tumor progression across Dukes A-D tumors; and no relationship between tumor stage and the number of microRNAs with significantly altered expression. Interaction analyses identified overall 41 genes, which discriminated early Dukes A plus B tumors from late Dukes C plus D tumor; 28 of these genes remained with correlations between genomic and transcriptomic alterations in Dukes C plus D tumors and 17 in Dukes D. One microRNA (microR-663) showed interactions with DNA alterations in all Dukes A-D tumors.


CONCLUSIONS
Our modeling confirms that colon cancer progression is related to genomic instability and altered gene expression. However, early invasive tumor growth seemed rather related to transcriptomic alterations, where changes in microRNA may be an early phenomenon, and less to DNA copy number changes.
Lagerstedt
Kristina K
KK
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden.
Kristiansson
Erik
E
Lönnroth
Christina
C
Andersson
Marianne
M
Iresjö
Britt-Marie
BM
Gustafsson
Annika
A
Hansson
Elisabeth
E
Kressner
Ulf
U
Nordgren
Svante
S
Enlund
Fredrik
F
Lundholm
Kent
K
Comput Biol Chem. 2009 Feb;33(1):94-9
18723399
Cancer Res. 2005 Nov 1;65(21):9603-6
16266975
BMC Syst Biol. 2008 Aug 10;2:72
18691435
Cell Res. 2008 Aug;18(8):823-33
18607389
Oncogene. 2004 Feb 19;23(7):1377-91
14973550
World J Surg. 2009 Apr;33(4):638-46
19123024
Nat Genet. 2009 Feb;41(2):178-186
19151715
Nucleic Acids Res. 2002 Feb 15;30(4):e15
11842121
BMC Genomics. 2005 May 10;6:69
15882471
BMC Cancer. 2006 Jul 12;6:186
16836752
JAMA. 2008 Jan 30;299(4):425-36
18230780
Cancer Res. 2008 Mar 1;68(5):1284-95
18316590
Cancer Lett. 2003 Feb 20;190(2):125-33
12565166
Leuk Lymphoma. 2007 Aug;48(8):1618-27
17701594
Cell Cycle. 2009 Feb 1;8(3):383-90
19177016
Cancer Res. 2004 Aug 15;64(16):5556-9
15313890
Am J Pathol. 2009 Feb;174(2):371-9
19147813
Mol Cancer Res. 2008 Apr;6(4):592-603
18403638
Breast Cancer Res. 2008;10(2):203
18373886
Genes Chromosomes Cancer. 2007 Jan;46(1):10-26
17044061
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9067-72
15199222
Int J Oncol. 2009 Apr;34(4):1069-75
19287964
Cancer Biol Ther. 2008 Mar;7(3):387-91
18717013
Mol Cancer. 2006 Jul 19;5:29
16854228
BMC Med Genet. 2008 Jul 21;9:70
18644122
Am J Hum Genet. 2008 Mar;82(3):723-36
18313025
Gastroenterology. 2002 Oct;123(4):1109-19
12360473
BMC Cancer. 2009 Oct 20;9:374
19843336
Cancer Res. 2004 Dec 1;64(23):8558-65
15574762
Clin Genet. 2009 Mar;75(3):220-4
19263514
N Engl J Med. 2009 Oct 8;361(15):1475-85
19812404
Endocr Relat Cancer. 2006 Sep;13(3):839-49
16954433
Oncol Rep. 2007 Oct;18(4):943-51
17786358
Cancer Immunol Immunother. 2009 Feb;58(2):281-90
18592235
Nature. 2009 Apr 9;458(7239):719-24
19360079
Genome Biol. 2004;5(10):R80
15461798
Cancer Inform. 2007 Oct 12;3:341-55
19455253
Gut. 2009 Jan;58(1):79-89
18829976
N Engl J Med. 2008 Aug 14;359(7):722-34
18703475
Biostatistics. 2004 Oct;5(4):557-72
15475419
BMC Cancer. 2009 Jan 14;9:17
19144156
Cancer Res. 2006 Feb 15;66(4):2129-37
16489013
Cancer Res. 2008 Aug 1;68(15):6416-24
18676867
Nat Cell Biol. 2008 Feb;10(2):202-10
18193036
Oncol Rep. 2006 Mar;15(3):667-71
16465428
Blood. 2009 Mar 12;113(11):2478-87
19147787
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903
12477932
Nature. 2008 Nov 6;456(7218):66-72
18987736
Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1733-45
17009964
N Engl J Med. 2009 Dec 17;361(25):2449-60
20018966
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Bioinformatics. 2003 Jan 22;19(2):185-93
12538238
Cancer Cell. 2006 Apr;9(4):313-25
16616336